Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.46% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXAR
1226
DELISTED
Exar Corporation
EXAR
| $7.13M | 0.02% |
1,162,662
-78,306
| -6% | -$480K |
|
1227
GSK
GSK
$107B
| $7.12M | 0.02% |
141,120
-1,003,360
| -88% | -$51.1M |
|
|
LABL
1228
DELISTED
Multi-Color Corp
LABL
| $7.1M | 0.02% |
118,700
-49,500
| -29% | -$3.4M |
|
1229
Neogen
NEOG
$2.05B
| $7.07M | 0.02% |
333,600
-393,715
| -54% | -$8.03M |
|
1230
Simmons First National
SFNC
$3.39B
| $7.06M | 0.02% |
275,000
+44,000
| +19% | +$1.16M |
|
1231
Civeo
CVEO
$356M
| $7.05M | 0.02% |
413,833
+28,922
| +8% | +$635K |
|
1232
KLA
KLAC
$222B
| $7.02M | 0.02% |
1,012,840
-1,342,000
| -57% | -$8.59M |
|
|
ASCMA
1233
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $7.02M | 0.02% |
419,900
+64,800
| +18% | +$1.39M |
|
1234
United Natural Foods
UNFI
$3.04B
| $7.02M | 0.02% |
178,350
-2,400
| -1% | -$112K |
|
1235
HealthStream
HSTM
$863M
| $7.01M | 0.02% |
318,500
-28,058
| -8% | -$655K |
|
|
GPOR
1236
DELISTED
Gulfport Energy Corp.
GPOR
| $6.99M | 0.02% |
284,600
-19,934
| -7% | -$561K |
|
1237
Camden National
CAC
$988M
| $6.97M | 0.02% |
237,300
+81,450
| +52% | +$2.32M |
|
1238
NGL Energy Partners
NGL
$1.94B
| $6.97M | 0.02% |
631,600
+568,986
| +909% | +$9.16M |
|
1239
SPS Commerce
SPSC
$2.55B
| $6.97M | 0.02% |
198,600
-4,600
| -2% | -$168K |
|
1240
Granite Construction
GVA
$5.16B
| $6.95M | 0.02% |
161,900
+94,700
| +141% | +$3.55M |
|
1241
Sunstone Hotel Investors
SHO
$2.19B
| $6.95M | 0.02% |
556,022
+167,342
| +43% | +$2.37M |
|
|
ELOS
1242
DELISTED
Syneron Medical Ltd
ELOS
| $6.94M | 0.02% |
900,606
-12,174
| -1% | -$92.8K |
|
|
COHR
1243
DELISTED
Coherent Inc
COHR
| $6.94M | 0.02% |
106,591
+4,391
| +4% | +$271K |
|
|
FPO
1244
DELISTED
First Potomac Realty Trust
FPO
| $6.93M | 0.02% |
608,364
+200,864
| +49% | +$2.3M |
|
1245
Eldorado Gold
EGO
$8.33B
| $6.93M | 0.02% |
466,800
+122,280
| +35% | +$2.06M |
|
|
SYNH
1246
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $6.92M | 0.02% |
142,700
+17,600
| +14% | +$783K |
|
1247
Valmont Industries
VMI
$8.86B
| $6.9M | 0.02% |
65,100
+49,900
| +328% | +$5.41M |
|
|
EEP
1248
DELISTED
Enbridge Energy Partners
EEP
| $6.88M | 0.02% |
298,212
+4,512
| +2% | +$113K |
|
|
BPFH
1249
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $6.88M | 0.02% |
606,300
+231,600
| +62% | +$2.69M |
|
|
CBI
1250
DELISTED
Chicago Bridge & Iron Nv
CBI
| $6.86M | 0.01% |
+175,930
| New | +$7.31M |
|
Similar funds
Renaissance Technologies's Q4 2015 Portfolio in Review
As of Q4 2015, Renaissance Technologies held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Renaissance Technologies deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Renaissance Technologies's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Renaissance Technologies added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Renaissance Technologies's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Renaissance Technologies fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Renaissance Technologies's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Renaissance Technologies opened 509 new positions and closed 386 in Q4 2015.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.